OncoArendi Therapeutics SA
Centrum Nauk Biologiczno-Chemicznych UW
Zwirki i Wigury 101
Warszawa
02-089
Tel: 48-22-552-67-24
Fax: 48-728-728-143
Website: https://oncoarendi.com
Email: contact@oncoarendi.com
About OncoArendi Therapeutics SA
OncoArendi Therapeutics (OAT) is an innovative biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics for neoplastic and inflammatory diseases.YEAR FOUNDED:
2012
LEADERSHIP:
CEO: Marcin Szymowski
CFO: Slawomir Broniarek
JOBS:
Please click here for OncoArendi Therapeutics job opportunities.
CLINICAL TRIAL:
Please click here for clinical trial information.
3 articles about OncoArendi Therapeutics SA
-
BioSpace Movers & Shakers, Feb. 4
2/4/2022
Biopharma and life sciences companies strengthen their boards and leadership teams with these Movers & Shakers. -
BioSpace Movers & Shakers, Jan. 28
1/28/2022
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers. -
OncoArendi Therapeutics SA Announces Selection Of Its Second Clinical Development Candidate: OATD-02 For The Treatment Of Multiple Cancers
6/21/2017